FINWIRES · TerminalLIVE
FINWIRES

Cleanaway Waste Management Fiscal 2027 Free Cash Flow Inflection Point Guidance Encouraging, Says Jarden

By

-- Cleanaway Waste Management (ASX:CWY) expects that a 'free cash flow inflection point' will arrive in fiscal 2027, which is encouraging and largely congruent with Visible Alpha expectations, according to a Tuesday Jarden note.

The research firm believes that investors are largely taking a "prove it" approach to the improvement in free cash flow to fiscal 2030, which could be demonstrated by the company in the second half of fiscal 2026.

Jarden sees the second half of the fiscal year as a critical juncture for Cleanaway to demonstrate that future organic earnings growth can be supported by strong free cash generation, while delivering forecast dividends.

Jarden maintained a buy rating on Cleanaway Waste Management with a price target of AU$3.10.

The company's shares rose 3% in recent Wednesday trade.

Related Articles

Asia

Brightstar Resources Reports Higher March Quarter Group Mining Production

Brightstar Resources (ASX:BTR) said its group mining production for the March quarter came in at 58,700 tonnes at 3.3 grams per tonne (g/t) grade of gold for 6,250 ounces from its Laverton underground mining operations in Western Australia, according to a Wednesday Australian bourse filing.The company's group mining production for the March 2025 quarter came in at 28,200 tonnes at 3.3 g/t grade of gold for 3,002 ounces from its Laverton underground mining operations in Western Australia, per the filing.During the quarter, the Fish underground mine was transitioned to care and maintenance, with mining operations ceasing and the mine positioned to be ready for the recommencement of ore production in early 2027.The mining development and closure proposal for Lady Shenton open pit mine in Menzies was approved, the filing said.Brightstar Resources' shares fell nearly 1% in recent trading on Wednesday.

$ASX:BTR
Asia

Racura Oncology, University of Wollongong Win New South Wales Government Funding for Cancer Study

Racura Oncology (ASX:RAC) and the University of Wollongong secured funding under the New South Wales government's TechVouchers program to study the efficacy of (E,E)-bisantrene for certain types of breast and ovarian cancers, according to a Wednesday filing with the Australian bourse.A collaboration between Racura and the University aims to produce preclinical evidence for the development of RC220 as a new targeted therapy, per the filing.Results from the collaboration are expected to come out over the next 12 months.Racura Oncology shares gained 2% in recent Wednesday trade.

$ASX:RAC
Asia

JAC Motors Widens Q1 Loss, Revenue Up 17%

Anhui Jianghuai Automobile (SHA:600418), or JAC Motors, posted first-quarter attributable net loss of 606.0 million yuan, compared with 223.0 million yuan the previous year.Loss per share widened to 0.27 yuan from 0.10 yuan, according to a Wednesday filing with the Shanghai bourse.The automobile company's operating revenue went up 17% year over year to 11.5 billion yuan from 9.80 billion yuan.

$SHA:600418